Reports Thu Jul 30Before open7:15 AM ETConfirmed
Baxter reports Q2 earnings at 7:15 AM ET as investors await updates on IV fluid production constraints and whether supply chain recovery is flowing through to margins.
![BAX logo]()
Baxter International :
BAX
BAX
Stock Data
$0.00
$0.00 (0.00%)
Asset Type
N/A
Exchange
N/A
Currency
N/A
Country
N/A
Sector
N/A
Industry
N/A
Baxter International Inc. is a global healthcare company that provides a wide range of medical products and services. Its offerings include sterile IV solutions, infusion systems, nutrition therapies, generic injectables, surgical equipment, patient monitoring technologies, and kidney care therapies. Baxter caters to hospitals, dialysis centers, nursing homes, and patients at home, selling its products in about 100 countries. The company focuses on improving patient care in areas like acute liver failure through partnerships and research collaborations. Founded in 1931, Baxter is headquartered in Deerfield, Illinois.
Latest Activity
Q2 2026
EPS
$0.56
est $0.37+52.5%
Revenue
$2.96B
est $2.80B+5.9%
Baxter International beat Q2 EPS by 52% and lifted full-year guidance after all segments posted organic growth, with a $0.11-per-share tariff refund sealing the beat. Advanced Surgery drove particularly strong momentum with 12% organic growth, though gross margins compressed 210 basis points year-over-year as higher-cost inventory from late 2025 rolled through cost of sales.
All Baxter International Articles
80 Articles
